New study reveals remarkable changes in how hallucinogenic drugs are perceived by American psychiatrists.Read More
Plummeting rates of ED visits for suicidal ideation and overall behavioral health in a new Cleveland Clinic study are a wake-up call to providers and the public at large.
The case of a 62-year-old woman hospitalized for COVID-19 shows how anxiety-induced hyperventilation can compromise lung function — and how effective anxiety treatment can promote overall recovery.
New practices prompted by the pandemic promise to enhance mental health care offerings to patients and healthcare providers in ways that will endure after the crisis ends.
Our Mellen Center for Multiple Sclerosis has been promoting wellness practices and stress management for years. As patient needs spike during the pandemic, virtual visits are ensuring continuity of care.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
A large data-mining study shows that digital conversations provide a needed emotional outlet for teens and adults coping with epilepsy and can help physicians better understand their patients’ mindsets.
Acute agitation in pregnancy jeopardizes the safety of both the patient and fetus. Dr. Adele Viguera, Associate Director of Cleveland Clinic’s Perinatal and Reproductive Psychiatry Program, explains how to evaluate for acute agitation in pregnant women, what treatments are safest, and the importance of applying a stepwise approach to interventions.
From increased risks to effective screening approaches, special pediatric considerations and the role of medications, our expert shares insights on the intersection of seizures and suicidality.
Child and adolescent psychiatrists are increasingly asked to work with transgender youth, but many have no training with this patient population. An expert shares his approach.
This novel infusion therapy could be a breakthrough for postpartum depression, but its administration is complex and highly regulated. Three psychiatrists outline how we’ll introduce it in our health system.
The newly approved intranasal ketamine derivative helps fill clear gaps in short-term therapy, says one expert, but questions remain around its long-term effects and affordability.